• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Oncology

Lung cancer screening may lower motivation for smoking cessation

byShayna BejaimalandJames Jiang
July 28, 2015
in Oncology, Public Health, Pulmonology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Although lung cancer screening gave patients the opportunity to reevaluate their health, routine screening may also lower a patient’s motivation for smoking cessation.

2. A concerning misperception amongst smokers is the belief that undergoing imaging testing yields the same benefits as smoking cessation.

Evidence Rating Level: 3 (Fair)

Study Rundown: The most effective method to decrease the risk of lung cancer in smokers is obviously smoking cessation. However, following the publication of National Lung Screening Trial, many healthcare providers have begun offering lung cancer screening. However, it is still important to ensure that screening is not perceived as a substitute for smoking cessation. This study aimed to determine how the availability of screening influences patient’s motivations regarding cessation.

In this survey study, 49% of interviewees described that lung cancer screening lowered their motivation for smoking cessation, and endorsed the misperception that image screening provides the same health benefits as quitting. Other concerning beliefs included the perceptions that everyone benefits from screening, screening accurately determines your risk of cancer, screening catches your cancer early and may have saved their lives, screening reduces the need to have to undergo cancer treatment, and that a negative screening result deemphasizes the personal harm from smoking. Strengths of this study include use of semi-structured interview style to encourage rich description of participants’ perceptions. However, the study is limited by having a low participation rate, and by not having quantitative analysis for quitting rates.

Click to read the study, published today in JAMA Internal Medicine

Relevant Reading: Reduced lung cancer mortality with low-dose computed tomographic screening

RELATED REPORTS

Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers

The RAPTURE trial: Radiofrequency ablation effective and safe in lung cancer [Classics Series]

Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial

In-Depth [survey]: This qualitative interview study conducted 45 in-depth semi-structured qualitative telephone interviews with 37 patients from the Veterans Health Administration, regarding health beliefs related to smoking and lung cancer screening. The surveys were conducted between May and September 2014. The 37 participants were current smokers who were offered lung cancer screening by their primary care physicians. Data was analyzed from June 2014 to March 2015. Statistical analysis includes simultaneous deductive and inductive content analysis with a priori determined thematic codes.

In all, 37 of the 186 patients approached took part in the study, resulting in a participation rate of 19.9%. There were no significant differences in demographic characteristics of veterans who participated and those who declined. Three major themes relating to how lung cancer screening may impact attitudes around smoking cessation were identified, including that universal screening evokes multiple complex emotions about smoking in participants, that screening is seen as an external method of change which contrasts the internal challenge of quitting smoking, and that screening may wrongfully emphasize cancer as main harm from smoking while ignoring cardiovascular risks. Five misperceptions were identified, including that screening was a highly valuable service because everyone receives a benefit, belief that screening provides a more precise estimate of their risk of developing cancer, the perception that detection of a nodule meant that screening worked for the participant and caught the cancer early at a harmless stage, belief that screening reduced the likelihood of needing cancer treatment, and the underestimation of the personal harm from smoking.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: lung cancersmoking cessation
Previous Post

Blood pressure variability associated with cardiovascular disease and mortality

Next Post

Aromatase inhibitors superior to tamoxifen in reducing ER positive breast cancer recurrence

RelatedReports

Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Chronic Disease

Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers

July 1, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Hematology/Oncology Classics

The RAPTURE trial: Radiofrequency ablation effective and safe in lung cancer [Classics Series]

July 1, 2022
Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Chronic Disease

Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial

June 15, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Radiology Classics

Fleischner Society Guidelines, 2005 Statement: Limited CT follow-up recommended for small, solitary, pulmonary nodules [Classics Series]

June 14, 2022
Next Post
Conjugated equine estrogens may elevate risk of venous thrombosis

Aromatase inhibitors superior to tamoxifen in reducing ER positive breast cancer recurrence

Adjuvant breast cancer treatment associated with additional cancer risk

Improved self reported coverage and access following ACA open enrollment

Designer molecule targets key protein in tenosynovial giant-cell tumor

Designer molecule targets key protein in tenosynovial giant-cell tumor

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]
  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.